Showing results (61-70 of 80) with videos related to
Sort By:
Pageof 8
Reviews of Infectious Diseases|July 1, 1990
2',3'-Dideoxyinosine in patients with AIDS or AIDS-related complexR Dolin, J S Lambert, G D Morse, et al.The Journal of Infectious Diseases|February 1, 1995
Phase I study of atevirdine, a nonnucleoside reverse transcriptase inhibitor, in combination with zidovudine for human immunodeficiency virus type 1 infection. ACTG 199 Study TeamR C Reichman, G D Morse, L M Demeter, et al.Sexually Transmitted Diseases|July 1, 1996
Therapeutic efficacy and complications of excisional biopsy of condyloma acuminatumW Bonnez, D Oakes, A Choi, et al.Antimicrobial Agents and Chemotherapy|February 19, 2000
Delavirdine susceptibilities and associated reverse transcriptase mutations in human immunodeficiency virus type 1 isolates from patients in a phase I/II trial of delavirdine monotherapy (ACTG 260)L M Demeter, R W Shafer, P M Meehan, et al.Annals of Internal Medicine|July 15, 1990
Toxicity of combined ganciclovir and zidovudine for cytomegalovirus disease associated with AIDS. An AIDS Clinical Trials Group StudyH Hochster, D Dieterich, S Bozzette, et al.The New England Journal of Medicine|May 10, 1990
2',3'-dideoxyinosine (ddI) in patients with the acquired immunodeficiency syndrome or AIDS-related complex. A phase I trialJ S Lambert, M Seidlin, R C Reichman, et al.Antiviral Research|November 1, 1988
Interferon alpha-n1 (Wellferon) for refractory genital warts: efficacy and tolerance of low dose systemic therapyR C Reichman, J P Micha, P K Weck, et al.Antiviral Research|June 1, 1997
A randomized, double-blind trial of parenteral low dose versus high dose interferon-beta in combination with cryotherapy for treatment of condyloma acuminatumW Bonnez, D Oakes, A Bailey-Farchione, et al.The Journal of Infectious Diseases|December 1, 1990
Treatment of condyloma acuminatum with three different interferon-alpha preparations administered parenterally: a double-blind, placebo-controlled trialR C Reichman, D Oakes, W Bonnez, et al.The Journal of Infectious Diseases|April 25, 2001
A Phase 1 study of a recombinant viruslike particle vaccine against human papillomavirus type 11 in healthy adult volunteersT G Evans, W Bonnez, R C Rose, et al.Pageof 8